Dacarbazine
Concept
Vocabulary Service
Overview
subject area of
-
A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma Academic Article
-
ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma Academic Article
-
An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma Academic Article
-
Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma Academic Article
-
Current approaches to the treatment of advanced-stage Hodgkin's disease. Academic Article
-
DTIC therapy in metastatic malignant melanoma: a simplified dose schedule. Academic Article
-
Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme Academic Article
-
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalatedPlus Four Cycles of BEACOPPbaselinein Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial Academic Article
-
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6 Academic Article
-
Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma? Academic Article
-
Multifocal neurotoxicity during interleukin-2 therapy for malignant melanoma Academic Article
-
Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma Academic Article
-
Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy Academic Article
-
Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Extent of Resection Academic Article
-
Paraspinal Synovial Sarcoma as an Unusual Postradiation Complication in Pediatric Abdominal Neuroblastoma Academic Article
-
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma Academic Article
-
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O6-methylguanine DNA methyltransferase expression Academic Article
-
Radiation in early-stage Hodgkin lymphoma. Academic Article
-
Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group Academic Article
-
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma Academic Article
-
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group. Academic Article
-
Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy Academic Article
-
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG) Academic Article
-
Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study Academic Article
-
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group. Academic Article
-
VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma Academic Article